Matches in Wikidata for { <http://www.wikidata.org/entity/Q72143102> ?p ?o ?g. }
Showing items 1 to 65 of
65
with 100 items per page.
- Q72143102 description "article scientifique publié en 1995" @default.
- Q72143102 description "artikull shkencor i botuar më 01 janar 1995" @default.
- Q72143102 description "artículu científicu espublizáu en xineru de 1995" @default.
- Q72143102 description "im Januar 1995 veröffentlichter wissenschaftlicher Artikel" @default.
- Q72143102 description "scientific article published on 01 January 1995" @default.
- Q72143102 description "wetenschappelijk artikel" @default.
- Q72143102 description "наукова стаття, опублікована в січні 1995" @default.
- Q72143102 name "A phase II trial of dacarbazine, fluorouracil and epirubicin in patients with neuroendocrine tumours. A study by the Italian Trials in Medical Oncology (I.T.M.O.) Group" @default.
- Q72143102 name "A phase II trial of dacarbazine, fluorouracil and epirubicin in patients with neuroendocrine tumours. A study by the Italian Trials in Medical Oncology (I.T.M.O.) Group" @default.
- Q72143102 name "A phase II trial of dacarbazine, fluorouracil and epirubicin in patients with neuroendocrine tumours. A study by the Italian Trials in Medical Oncology (I.T.M.O.) Group" @default.
- Q72143102 type Item @default.
- Q72143102 label "A phase II trial of dacarbazine, fluorouracil and epirubicin in patients with neuroendocrine tumours. A study by the Italian Trials in Medical Oncology (I.T.M.O.) Group" @default.
- Q72143102 label "A phase II trial of dacarbazine, fluorouracil and epirubicin in patients with neuroendocrine tumours. A study by the Italian Trials in Medical Oncology (I.T.M.O.) Group" @default.
- Q72143102 label "A phase II trial of dacarbazine, fluorouracil and epirubicin in patients with neuroendocrine tumours. A study by the Italian Trials in Medical Oncology (I.T.M.O.) Group" @default.
- Q72143102 prefLabel "A phase II trial of dacarbazine, fluorouracil and epirubicin in patients with neuroendocrine tumours. A study by the Italian Trials in Medical Oncology (I.T.M.O.) Group" @default.
- Q72143102 prefLabel "A phase II trial of dacarbazine, fluorouracil and epirubicin in patients with neuroendocrine tumours. A study by the Italian Trials in Medical Oncology (I.T.M.O.) Group" @default.
- Q72143102 prefLabel "A phase II trial of dacarbazine, fluorouracil and epirubicin in patients with neuroendocrine tumours. A study by the Italian Trials in Medical Oncology (I.T.M.O.) Group" @default.
- Q72143102 P1433 Q72143102-2724FD8A-55B5-43A6-A1AD-E6BE0CB7F93F @default.
- Q72143102 P1476 Q72143102-D9A49AB1-7111-407F-B01C-A62436B4F076 @default.
- Q72143102 P2093 Q72143102-07D078C8-975A-4686-A5F1-349BFE902EB5 @default.
- Q72143102 P2093 Q72143102-155D0A72-1769-43A1-A5C6-7E01FB9300D5 @default.
- Q72143102 P2093 Q72143102-177E26AC-6C0C-4F72-9446-4C39CFC95E10 @default.
- Q72143102 P2093 Q72143102-20996480-8A6B-4800-B0C5-E40F8E592926 @default.
- Q72143102 P2093 Q72143102-58FD74D9-F384-405E-BB34-B0A12503F78D @default.
- Q72143102 P2093 Q72143102-6E7408E0-7BD6-4281-AE56-EDCF2118E897 @default.
- Q72143102 P2093 Q72143102-B632144C-AB5D-4611-8014-F652BAF01343 @default.
- Q72143102 P2093 Q72143102-BFE8032B-F7E4-4BBD-A6B5-58105864CB14 @default.
- Q72143102 P2093 Q72143102-C9692E8F-0022-4F78-A7A3-E84198A8C9E9 @default.
- Q72143102 P2093 Q72143102-DFA82E05-DED0-4319-BB75-34C7D328035D @default.
- Q72143102 P304 Q72143102-944349AD-874C-4E13-9278-8CA3391C6D29 @default.
- Q72143102 P31 Q72143102-54814A52-F5B6-4F97-9856-FC41A4068426 @default.
- Q72143102 P356 Q72143102-6230164E-389B-4A01-BDD3-466CAE204896 @default.
- Q72143102 P433 Q72143102-5C34393F-6C1F-4AED-A91A-CD0D07D454EF @default.
- Q72143102 P478 Q72143102-787601E1-81DE-436B-A1AB-F07FA34257D9 @default.
- Q72143102 P577 Q72143102-C8347845-8451-43B2-8C44-073FA04DF2FD @default.
- Q72143102 P698 Q72143102-9C8D1A01-39E2-46E6-92D5-97E46063ED8B @default.
- Q72143102 P921 Q72143102-3DD021A1-24B8-4989-83C9-3D5992360E0B @default.
- Q72143102 P921 Q72143102-3FFDA84C-26ED-45EF-AFBE-D745D4E5D2C9 @default.
- Q72143102 P921 Q72143102-CB1AEFF5-AA56-44F0-AE4C-989BB64A086D @default.
- Q72143102 P921 Q72143102-F38D20A3-1ED0-44AB-A925-6DA524CA9661 @default.
- Q72143102 P356 OXFORDJOURNALS.ANNONC.A059049 @default.
- Q72143102 P698 7710986 @default.
- Q72143102 P1433 Q326122 @default.
- Q72143102 P1476 "A phase II trial of dacarbazine, fluorouracil and epirubicin in patients with neuroendocrine tumours. A study by the Italian Trials in Medical Oncology (I.T.M.O.) Group" @default.
- Q72143102 P2093 "A M Bochicchio" @default.
- Q72143102 P2093 "C Carnaghi" @default.
- Q72143102 P2093 "E Bajetta" @default.
- Q72143102 P2093 "L Somma" @default.
- Q72143102 P2093 "M Di Bartolomeo" @default.
- Q72143102 P2093 "M Visini" @default.
- Q72143102 P2093 "P Ballatore" @default.
- Q72143102 P2093 "S Tumolo" @default.
- Q72143102 P2093 "V Gebbia" @default.
- Q72143102 P2093 "V Mazzaferro" @default.
- Q72143102 P304 "77-79" @default.
- Q72143102 P31 Q13442814 @default.
- Q72143102 P356 "10.1093/OXFORDJOURNALS.ANNONC.A059049" @default.
- Q72143102 P433 "1" @default.
- Q72143102 P478 "6" @default.
- Q72143102 P577 "1995-01-01T00:00:00Z" @default.
- Q72143102 P698 "7710986" @default.
- Q72143102 P921 Q238512 @default.
- Q72143102 P921 Q416975 @default.
- Q72143102 P921 Q42824440 @default.
- Q72143102 P921 Q6050805 @default.